Published • loading... • Updated
Urvashi Prasad: India Accounts for Just 1.41% of Global Lung Cancer Clinical Trials Over 20 Years – OncoDaily
Summary by PressNewsAgency
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Urvashi Prasad: India Accounts for Just 1.41% of Global Lung Cancer Clinical Trials Over 20 Years – OncoDaily
Urvashi Prasad, Director of the Centre for Air Pollution and Environmental Health (PAVANA) at the Pahlé India Foundation, shared on LinkedIn: “1.41%. That is India’s share of the world’s lung cancer clinical trials over the last 20 years. Our share of the global disease burden is up to 5.7%. Our share of the world’s population is nearly 18%. At the International Association for the Study of Lung Cancer World Conference on Lung Cancer in Seoul, I…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
